Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OXiGENE Inc (NASDAQ:OXGN)

0.656
Delayed Data
As of Apr 29
 -0.044 / -6.29%
Today’s Change
0.49
Today|||52-Week Range
1.68
-13.67%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$17.4M

Company Description

Oxigene, Inc. is a biopharmaceutical company, which focus on the development of vascular disrupting agents, or VDAs, for the treatment of cancer. It products include VDAs-CA4P and OXi4503. The company was founded in 1988 and is headquartered in South San Francisco, CA.

Contact Information

Oxigene, Inc.
701 Gateway Boulevard
South San Francisco California 94080
P:(650) 635-7000
Investor Relations:

Employees

Shareholders

Other institutional5.00%
Mutual fund holders3.50%
Individual stakeholders0.64%

Top Executives

William D. SchwietermanPresident, Chief Executive Officer & Director
Matthew M. LoarChief Financial & Accounting Officer
David J. ChaplinChief Scientific Officer & Director
Kathleen M. LeeVice President-Chemistry, Manufacturing & Controls
Alice M. VargaVP-Regulatory Affairs & Quality Assurance